News for Timber Pharmaceuticals, Inc. (TMBR)

WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. (

WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutic...

WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE:TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for

NEW YORK, Aug. 27, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. (NYSE: TMBR) Lifshitz Law PLLC announces an investigation into possible...

NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

Wilmington, Delaware--(Newsfile Corp. - August 21, 2023) - Rigrodsky Law, P.A. is investigating Timber Pharmaceuticals, Inc. ('Timber') (NYSE: TMB...

NEW YORK, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded down 0.16% to 34,446.91 while the NASDAQ rose 1.52% to 13,492.73. The S&P 500, also rose, gaining, 0.55% to 4,393.55.

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.40% to 34,362.93 while the NASDAQ rose 0.78% to 13,394.60. The S&P 500, also rose, gaining, 0.12% to 4,374.89.

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.11% to 34,461.22 while the NASDAQ rose 0.95% to 13,416.64. The S&P 500, also rose, gaining, 0.39% to 4,386.63.

U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Monday. The Dow traded down 0.33% to 33,651.23 while the NASDAQ rose 0.30% to 13,279.88. The S&P 500, also rose, gaining, 0.11% to 4,286.88.

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 115.3% to $1.40 in pre-market trading after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.

DISCB and 6 Other Reddit Stocks Waiting for a Short Squeeze InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reddit stocks continue to show... | April 7, 2021

Looking for Biotech Penny Stocks to Watch? Here’s A Few For Your List With biotech penny stocks, it’s easy to find companies working on new treatments & me...

Today's Daily Dose brings you news about the regulatory set back of Athenex's oral Paclitaxel and CorMedix's Defencath, ASLAN Pharma's Atopic Dermatitis trial results, FDA panel review of FibroGen's Roxadustat, Morphic Therapeutic's Phase 1 single ascending dose clinical trial of MORF-057, which is in development for the treatment of inflammatory bowel disease, and STRATA Skin's CEO transition.

Penny Stocks For The Early-March Watch List As March gets off to a great start, investors continue to look for penny stocks with the best chance of profitabili...